Literature DB >> 19885161

Analysis of office-based glycohemoglobin measurement.

Trefor Higgins1.   

Abstract

Hemoglobin A1c (HbA1c) measurements are important for monitoring glycemic control in patients with diabetes. The positive impact of point-of-care HbA1c measurements on patient management is described in the literature. The general analytical requirements for HbA1c testing are described. The analytical evaluation of a new point-of-care HbA1c analyzer, suitable for a physician's office, against these requirements is described.

Entities:  

Keywords:  HbA1c; point of care

Year:  2007        PMID： 19885161      PMCID： PMC2769682          DOI： 10.1177/193229680700100613

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  12 in total

1.  Immediate assessment of HbA1c under field conditions in Tanzania.

Authors:  K Wikblad; B Smide; A Bergström; L Wahren; F Mugusi; J O Jeppsson
Journal:  Diabetes Res Clin Pract       Date:  1998-05       Impact factor: 5.602

2.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.

Authors:  E Cagliero; E V Levina; D M Nathan
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

3.  Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals.

Authors:  G Phillipou; P J Phillips
Journal:  Clin Chem       Date:  1993-11       Impact factor: 8.327

4.  Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.

Authors:  Michael Steffes; Patricia Cleary; David Goldstein; Randie Little; Hsiao-Mei Wiedmeyer; Curt Rohlfing; Jack England; Jean Bucksa; Maren Nowicki
Journal:  Clin Chem       Date:  2005-01-31       Impact factor: 8.327

5.  Interpretation of hemoglobin A(1c) (HbA(1c)) values among diabetic patients: implications for quality specifications for HbA(1c).

Authors:  S Skeie; G Thue; S Sandberg
Journal:  Clin Chem       Date:  2001       Impact factor: 8.327

6.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; David E Bruns; David E Goldstein; Noel K Maclaren; Jay M McDonald; Marian Parrott
Journal:  Clin Chem       Date:  2002-03       Impact factor: 8.327

7.  The national glycohemoglobin standardization program: a five-year progress report.

Authors:  R R Little; C L Rohlfing; H M Wiedmeyer; G L Myers; D B Sacks; D E Goldstein
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

8.  Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making.

Authors:  L M Thaler; D C Ziemer; D L Gallina; C B Cook; V G Dunbar; L S Phillips; I M El-Kebbi
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

9.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.